We report a rare case of an intra-osseous liposarcoma of the proximal femur. A 26-year-old man presented with a 6-month history of left groin pain radiating to the knee and an antalgic gait. Radiology showed a predominantly fatty lesion in the medial aspect of the femoral neck extending toward the lesser trochanter; most of the marrow in the femoral neck had been replaced without evidence of an extra-osseous mass; and the posterior cortex had been destroyed. Histological and immunohistochemical analyses of the tumour after open biopsy were indicative of highgrade liposarcomatous malignancy. After exclusion of any other primary tumour foci or metastases on regional and whole-body magnetic resonance images, the diagnosis of a high-grade intra-osseous primary liposarcoma of the proximal femur was made. The patient received 2 preoperative courses of neoadjuvant doxorubicin, cisplatin and methotrexate. After proximal femoral replacement following en bloc excision of the proximal femur, 4 more cycles of adjuvant ifosfamide and etoposide were given. At the 16-month follow-up, he remained independently ambulatory, with no local or distant recurrence. Tissue diagnosis and multimodal imaging, rather than any single radiological investigation, are important in making the diagnosis.
CASE REPORT
In June 2007 a 26-year-old man presented with a 6month history of left groin pain radiating to the knee and an antalgic gait. He had no signs of systemic disease or any history of trauma. Radiology showed a predominantly fatty lesion in the medial aspect of the femoral neck extending toward the lesser trochanter; most of the marrow in the femoral neck had been replaced without evidence of an extra-osseous mass; and the posterior cortex had been destroyed (Fig.  1) . These aggressive features were unusual for an indolent tumour such as an intra-osseous lipoma.
A fluoroscopy-guided biopsy failed to obtain adequate tissue for an accurate diagnosis, but the histology suggested an aggressive fat-containing neoplasm. An open biopsy and curettage was performed, followed by polymethylmethacrylate cementation and stabilisation with a dynamic hip screw (Fig. 2 ). The postoperative course was complicated by a small pulmonary embolus (confirmed by computed tomographic pulmonary angiography), and oral anticoagulation was prescribed.
Microscopically, the lesion did not contain osteoid or cartilaginous malignant differentiation. It comprised lobules of well-differentiated adipose tissue intermingled with atypical spindle cells with pleomorphic nuclei (Fig. 3 ). Lipoblasts and numerous atypical mitoses were identified. The fatty tissue showed scattered enlarged and hyperchromatic nuclei. There was no evidence of malignant osteoid or cartilaginous differentiation.
Immunohistochemistry showed that the tumour cells were negative for SM-actin, desmin, CD45, and pankeratin MNF116, thus excluding smooth muscle, neural, haematological and epithelial malignancies, respectively. Nonetheless, S100 immunostaining was positive in the well-differentiated fatty component indicating a liposarcomatous malignancy: either a primary intra-osseous liposarcoma or a bony metastasis from a primary soft-tissue sarcoma. Further staging radiological investigations of the chest and whole body excluded any extra-osseous spread of the tumour or other primary or metastatic lesions elsewhere.
The patient received 2 cycles of neoadjuvant doxyrubicin, cisplatin, and methotrexate to reduce the tumour size. In October 2007, he underwent a proximal femoral replacement following en bloc excision of the 
DISCUSSION
Liposarcomas are uncommon tumours of primitive mesenchymal derivation occurring mostly in adults, [1] [2] [3] [4] with an annual incidence of 2.5 per million in the US. They account for 10 to 15% of soft-tissue sarcomas. 5 Primary liposarcomas of the bone, arising from lipoblasts in the fatty bone marrow, are extremely rare and constitute <0.1% of primary bone tumours, 6 with a wide anatomic distribution (including the femur, [7] [8] [9] [10] [11] [12] [13] humerus, 3,14-17 tibia, 6,18-20 fibula, 21, 22 ulna, 23 spine, 24, 25 ilium, 10 scapula, 26 and skull [27] [28] [29] ). Less than 35 cases have been reported, 9 and only 20 of these fulfilled the criteria for primary liposarcoma of bone, 2 and only 16 had definitive photomicrographs. 3 High-grade soft-tissue liposarcomas do not respond well to treatment (including a combination of surgery and multimodal therapies). Five-year survival rates are <67%, with up to 50% of patients developing local recurrence or metastatic disease within 5 years, 7, 17, [30] [31] [32] [33] [34] and tumours may recur even 10 years after treatment. 35 Primary liposarcomas of the bone appear to follow a course similar to that of the soft-tissue liposarcomas, 10 and have a more favourable prognosis than osteosarcomas.
Of 23 cases of intra-osseous liposarcoma reviewed (Table) , no single treatment appeared to be wholly effective. Outcomes were extremely poor following radiotherapy alone; outcomes tended to be better in those who had radical surgery (amputations rather than resections). 11 (48%) patients died after a mean of 12 (range, 2-36) months, whereas 12 (52%) were alive at a mean follow-up of 33 (range, 5-144) months. 13 patients developed distant metastases following treatment, and one died from the disease after only 3 months. 25 Liposarcoma of the humerus appeared to have the worst outcome; those affecting the tibia appeared to have better survival rates, similar to the pattern seen in soft-tissue liposarcomas where survival rates are better in patients with lowerextremity tumours. 36 Only one patient had a followup period of >5 years, 1 thus no long-term survival can be inferred. No conclusions can be drawn about variations in prognosis based on tumour grade or subtype, because of the small number of patients with this tumour.
Our neoadjuvant and adjuvant chemotherapeutic treatment regimens were based on standard protocols used for soft-tissue liposarcomas. Doxorubicin was chosen as a neoadjuvant therapeutic agent to improve the chances of successful limb-sparing surgery, and because of its associated improved overall liposarcoma survival rates. 33 Unfortunately, our patient's initial response to doxorubicin was poor, so it was replaced by etoposide, along with the standard ifosfamide.
In view of the high rates of recurrence and metastasis, 31, 33, 35 surveillance for local recurrence and distant metastasis, including clinical examination and chest and regional radiology, should be performed every 3 months for the first 24 months, then 6 
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* DOD denotes dead of disease, ANED alive with no evidence of disease, AWED alive with evidence of disease monthly for 10 years. 33, 36 This case emphasises the importance of a tissue diagnosis and multimodal radiological imaging, rather than relying on any single investigation.
